Access to essential anticancer medicines for children and adolescents

Share :
Published: 6 Oct 2022
Views: 95
Prof Richard Sullivan and Dr Carlos Rodriguez-Galindo

Prof Richard Sullivan (Kings College London, London, UK) and Dr Carlos Rodriguez-Galindo (St. Jude Children's Research Hospital, Tennessee, USA) discuss access to essential paediatric cancer medicines.

Dr Galindo talks about the issues regarding access to essential childhood cancer medicines. The instability in the paediatric cancer medicine market across the world impacts accessibility to high-quality cancer treatment.

He explains the WHO's initiative to create a stable supply of paediatric medicines and access to improved treatments in countries that need them.

Dr Galindo expands on what a global solution looks like. He concludes by talking about the role of this procurement model in the adult cancer treatment world.